Nifedipine Medication Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	June, 2023	CMI18107582

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18107582

Nifedipine Medication Market, By Dosage Form (Tablets, Extended-Release Tablets, Capsules), By Indication (Hypertension, Angina Pectoris, Raynaud\'s Phenomenon), By Distribution Channel (Hospitals and Clinics, Retail Pharmacies, Online Pharmacies), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Nifedipine is a calcium channel blocker that is frequently utilized in the treatment of hypertension (also known as high blood pressure) as well as certain cardiovascular disorders. It includes both branded and generic versions of nifedipine, as well as a variety of dosage forms including tablets, capsules, and extended-release formulations.

Market Dynamics:

A growing number of people suffering from hypertension and cardiovascular illnesses and increasing aging population are major factors expected to drive growth of the global nifedipine medication market during the forecast period.

However, patent expiration, regulatory challenges, adverse effects, availability of alternative treatments, shifting treatment paradigms, pricing pressures are expected to hamper the growth of the global nifedipine medication market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global nifedipine medication market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global nifedipine medication market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Johnson & Johnson, GlaxoSmithKline plc, Lupin Limited , Sun Pharmaceutical Industries Ltd., Sandoz International GmbH (a Novartis division) Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd, Apotex Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global nifedipine medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nifedipine medication market.

Detailed Segmentation:

Global Nifedipine Medication Market, By Dosage Form:
Tablets
Extended-Release Tablets
Capsules
Global Nifedipine Medication Market, By Indication:
Hypertension
Angina Pectoris
Raynaud's Phenomenon
Global Nifedipine Medication Market, By Distribution Channel:
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
Global Nifedipine Medication Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
AstraZeneca PLC
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sanofi S.A.
Johnson & Johnson
GlaxoSmithKline plc
Lupin Limited
Sun Pharmaceutical Industries Ltd.
Sandoz International GmbH (a Novartis division)
Dr. Reddy's Laboratories Ltd.
Torrent Pharmaceuticals Ltd.
Apotex Inc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Dosage Form; Market Snapshot, By Indication; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; A growing number of people suffering from hypertension and cardiovascular illnesses; Patent expiration, regulatory challenges, and adverse effects; Emerging markets, partnerships and collaborations; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Nifedipine Medication Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Nifedipine Medication Market, By Dosage Form, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 - 2030; Segment Trends; Tablets; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Extended-Release Tablets; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Tablets Capsules; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Global Nifedipine Medication Market, By Indication, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 - 2030; Segment Trends; Hypertension; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Angina Pectoris; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Raynaud's Phenomenon; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
7. Global Nifedipine Medication Market, By Distribution Channel, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 - 2030; Segment Trends; Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
8. Global Nifedipine Medication Market, By Region, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 - 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
9. Competitive Landscape: Pfizer Inc; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Novartis AG; Merck & Co., Inc.; AstraZeneca PLC; Teva Pharmaceutical Industries Ltd; Mylan N.V.; Sanofi S.A.; Johnson & Johnson; GlaxoSmithKline plc; Lupin Limited; Sun Pharmaceutical Industries Ltd.; Sandoz International GmbH (a Novartis division); Dr. Reddy's Laboratories Ltd.; Torrent Pharmaceuticals Ltd.; Apotex Inc.; Analyst Views
10. Section: Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Nifedipine Medication Market” - forecast to 2030